Is Tilray's BrewDog Already Backfiring? Market Check
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Timing matters: restructuring is best when income changes or spending diverges from goals.
16,677 articlesTilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Investors are watching Appleās latest Siri reveal to see if it marks a meaningful AI leap or just another upgrade. Th...
Greg Abel is stepping into a part of the market Warren Buffett mostly left untouched. This article breaks down what A...
As Micron prepares to report on June 24, three solid reasons could justify a closer look at MU. This guide breaks dow...
Urban air taxis are moving from concept to reality. This article explores Joby Aviation, the eVTOL pioneer, and wheth...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
As the 2026 COLA lands at 2.8%, retirees face a growing gap between checks and living costs. A disciplined four-ETF i...
A practical look at a top energy stock evolving at the crossroads of renewables and AI. Learn how to assess the setup...
When spacex officially joined nasdaq-100, investors expected a jump in demand. Instead, the stock price moved lower a...
A 68-year-old investor locks in Social Security and tax moves as markets wobble. The hardest retirement money decisio...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...